Celyad

About:

Celyad is a provider of cell therapy treatments with an initial focus on cardiology and oncology.

Website: http://www.celyad.com

Twitter/X: CelyadSA

Top Investors: Grifols, Fortress Investment Group, S.R.I.W., Life Sciences Research Partners V.Z.W., Tolefi Group

Description:

Celyad is a biopharmaceutical company, specialized in cell therapy. It develops technologies and treatments to treat severe diseases with poor prognosis. The company focuses on Immuno oncology, Cardiology, and Medical devices. Its main product candidates include CAR-T NKR-2, C-Cure. The firm has CYAD-01, CYAD-02, CYAD-03 programs in pipeline. The company owns trademarks and service marks including CELYAD, C-CATH, C_CURE, CATH and C-CATHez and CARDIO 3 BIOSCIENCES. The firm has Cardiology and Immuno-oncology operating segments.